|
A more recent version of this article appeared on March 10, 2006
Originally published In Press as doi:10.1074/jbc.M513118200 on January 5, 2006
Papers In Press, published online ahead of print December 23, 2005
J. Biol. Chem, 10.1074/jbc.M513118200
Submitted on December 8, 2005
Accepted on December 23, 2005
The structure of the IL-15 -receptor and its implications for ligand binding
Inken Lorenzen, Andrew J. Dingley, Yannick Jaques, and Joachim Grötzinger
Biochemistry Dept., University of Kiel, Kiel 24098
Corresponding Author: jgroetzinger{at}biochem.uni-kiel.de
Interleukin-15 (IL-15) is a member of the small four a-helix bundle family of cytokines. IL-15 was discovered by its ability to mimic Interleukin-2 (IL-2) mediated T cell-proliferation. Both cytokines share the b-and g-receptor chains of the IL-2 receptor for signaltransduction. However, in addition they target specific a-chain receptors, the IL-15Ra and IL-2Ra, respectively. The exceptionally high-affinity binding of IL-15 to the IL-15Ra is mediated by its sushi domain. Here we present the solution structure of the IL-15Ra sushi domain solved by NMR spectroscopy and a model of its complex with IL-15. The model shows that rather than the familiar hydrophobic forces dominating the interaction interface between cytokines and their cognate receptors, the interaction between IL-15 and IL-15Ra complex involves a large network of ionic interactions. This type of interaction explains the exceptionally high affinity of the IL-15/IL-15Ra complex, which is essential for the biological effects of this important cytokine and that is not observed in other cytokine/cytokine receptor complexes.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. P. Carroll, V. Paunovic, and M. Gadina
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity
Rheumatology,
September 1, 2008;
47(9):
1269 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Duitman, Z. Orinska, E. Bulanova, R. Paus, and S. Bulfone-Paus
How a Cytokine Is Chaperoned through the Secretory Pathway by Complexing with Its Own Receptor: Lessons from Interleukin-15 (IL-15)/IL-15 Receptor {alpha}
Mol. Cell. Biol.,
August 1, 2008;
28(15):
4851 - 4861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Olsen, N. Ota, S. Kishishita, M. Kukimoto-Niino, K. Murayama, H. Uchiyama, M. Toyama, T. Terada, M. Shirouzu, O. Kanagawa, et al.
Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor {alpha} Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION
J. Biol. Chem.,
December 21, 2007;
282(51):
37191 - 37204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rafei, J. H. Wu, B. Annabi, L. Lejeune, M. Francois, and J. Galipeau
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex
Blood,
March 1, 2007;
109(5):
2234 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Rubinstein, M. Kovar, J. F. Purton, J.-H. Cho, O. Boyman, C. D. Surh, and J. Sprent
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}
PNAS,
June 13, 2006;
103(24):
9166 - 9171.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|